Education and Training
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial.
Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: phototherapy
Eligibility
Inclusion Criteria:
- birth weight 401-1000 grams
- age less than or equal to 24 hours
Exclusion Criteria:
- hemolytic disease
- major anomaly
- overt nonbacterial infection
Ages Eligible for Study
N/A - 24 Hours
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
David K Stevenson, MD
497-0735
I'm interested